- Home
- FTEL vs BCLI Comparison
FTEL vs BCLI Comparison
Compare FTEL & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEL
- BCLI
- Stock Information
- Founded
- FTEL 2007
- BCLI 2000
- Country
- FTEL Australia
- BCLI United States
- Employees
- FTEL N/A
- BCLI N/A
- Industry
- FTEL
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTEL
- BCLI Health Care
- Exchange
- FTEL Nasdaq
- BCLI Nasdaq
- Market Cap
- FTEL 9.6M
- BCLI 7.9M
- IPO Year
- FTEL 2023
- BCLI N/A
- Fundamental
- Price
- FTEL $0.54
- BCLI $1.16
- Analyst Decision
- FTEL
- BCLI Strong Buy
- Analyst Count
- FTEL 0
- BCLI 1
- Target Price
- FTEL N/A
- BCLI $30.00
- AVG Volume (30 Days)
- FTEL 110.4K
- BCLI 141.4K
- Earning Date
- FTEL 05-27-2025
- BCLI 05-15-2025
- Dividend Yield
- FTEL N/A
- BCLI N/A
- EPS Growth
- FTEL N/A
- BCLI N/A
- EPS
- FTEL N/A
- BCLI N/A
- Revenue
- FTEL $4,990,695.00
- BCLI N/A
- Revenue This Year
- FTEL N/A
- BCLI N/A
- Revenue Next Year
- FTEL N/A
- BCLI N/A
- P/E Ratio
- FTEL N/A
- BCLI N/A
- Revenue Growth
- FTEL 29.02
- BCLI N/A
- 52 Week Low
- FTEL $0.43
- BCLI $0.72
- 52 Week High
- FTEL $49.50
- BCLI $10.05
- Technical
- Relative Strength Index (RSI)
- FTEL 40.21
- BCLI 50.13
- Support Level
- FTEL $0.48
- BCLI $1.12
- Resistance Level
- FTEL $0.54
- BCLI $1.26
- Average True Range (ATR)
- FTEL 0.06
- BCLI 0.14
- MACD
- FTEL 0.03
- BCLI 0.02
- Stochastic Oscillator
- FTEL 53.20
- BCLI 42.86
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.